Emulate Revenue and Competitors
Estimated Revenue & Valuation
- Emulate's estimated annual revenue is currently $21.7M per year.
- Emulate received $36.0M in venture funding in June 2018.
- Emulate's estimated revenue per employee is $155,000
- Emulate's total funding is $224.3M.
- Emulate has 140 Employees.
- Emulate grew their employee count by 27% last year.
What Is Emulate?
We work at the intersection of biology, engineering, and design, developing technologies that emulate human biology. Our products are enabling a new era of precision medicine and the development of applications for personalized health. Our Human Emulation System, which uses Organs-on-Chips technology, is being used by industry, government, and academia to understand how different diseases, medicines, chemicals and foods affect human health. The system offers researchers a new standard for predicting human response - with greater precision and control than today's cell culture or animal-based experimental methods. We are also leading a bold, new precision medicine initiative with our clinical partners. Named "Patient-on-a-Chip," the program is developing personalized chips with patients' own cells. This initiative will help transform the way each of us understands our own bodies and manages our own health. Research conducted using our Organ-Chips has been published in high-impact scientific journals, including Science. In addition, Organ-Chips have been acquired by the Museum of Modern Art (MoMA) in New York for their permanent collection, and have also been awarded Product Design of the Year 2015 by London's Design Museum. Our founding team pioneered the original Organs-on-Chips technology during their residency within the Wyss Institute for Biologically Inspired Engineering at Harvard University.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
BOSTON, May 18, 2021 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today launched the Emulate Colon Intestine-Chip Grant Program. The program will help researchers begin using Organs-on-Chips technology to study intestinal diseases. The Emulate Colon Intestine- ...
Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 mill ...
Emulate, Inc., a Boston, MA-based provider of next generation in vitro models, closed an $82m Series E financing round. The round, which brought total funding raised to date to nearly $225m, was led by existing investor Northpond Ventures with participation from Perceptive Advisors. The compan ...
Wales manager Ryan Giggs has backed Aaron Ramsey to find success at Juventus, saying the Arsenal midfielder can emulate Real Madrid
Maple Leaf could have blamed sloppy employees for the deadly listeria outbreak. It could have blamed faulty machinery. It could have blamed
Since being selected with the top pick in the 2016 draft, Simmons has drawn comparisons with five-time NBA champion Johnson, due to his
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|